MicroRNAs as modulators and biomarkers of inflammatory and neuropathic pain conditions
The post-transcriptional regulator molecules, microRNAs, have emerged as important biomarkers and modulators of numerous pathophysiological processes including oncogenesis and cardiovascular diseases. Recently, a significant number of dysregulations in microRNAs have been reported in patients suffer...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Andersen, Hjalte H. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2014transfer abstract |
|---|
| Umfang: |
10 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Rational administration sequencing of immunochemotherapy elicits powerful anti-tumor effect - Zhu, Chunqi ELSEVIER, 2021, Orlando, Fla |
|---|---|
| Übergeordnetes Werk: |
volume:71 ; year:2014 ; pages:159-168 ; extent:10 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.nbd.2014.08.003 |
|---|
| Katalog-ID: |
ELV039427641 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV039427641 | ||
| 003 | DE-627 | ||
| 005 | 20230625224900.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180603s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.nbd.2014.08.003 |2 doi | |
| 028 | 5 | 2 | |a GBVA2014016000006.pica |
| 035 | |a (DE-627)ELV039427641 | ||
| 035 | |a (ELSEVIER)S0969-9961(14)00232-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 |a 570 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 570 |q DE-600 |
| 082 | 0 | 4 | |a 540 |a 610 |q VZ |
| 084 | |a 15,3 |2 ssgn | ||
| 084 | |a PHARM |q DE-84 |2 fid | ||
| 084 | |a 44.40 |2 bkl | ||
| 084 | |a 58.28 |2 bkl | ||
| 100 | 1 | |a Andersen, Hjalte H. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a MicroRNAs as modulators and biomarkers of inflammatory and neuropathic pain conditions |
| 264 | 1 | |c 2014transfer abstract | |
| 300 | |a 10 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a The post-transcriptional regulator molecules, microRNAs, have emerged as important biomarkers and modulators of numerous pathophysiological processes including oncogenesis and cardiovascular diseases. Recently, a significant number of dysregulations in microRNAs have been reported in patients suffering from painful disorders such as complex regional pain syndrome, cystitis-induced chronic pain and irritable bowel disorder, in both affected tissues and the circulation. Moreover, microRNAs are known to be involved in pain processing based on several recent findings in animal models of inflammatory and neuropathic pain. | ||
| 520 | |a The post-transcriptional regulator molecules, microRNAs, have emerged as important biomarkers and modulators of numerous pathophysiological processes including oncogenesis and cardiovascular diseases. Recently, a significant number of dysregulations in microRNAs have been reported in patients suffering from painful disorders such as complex regional pain syndrome, cystitis-induced chronic pain and irritable bowel disorder, in both affected tissues and the circulation. Moreover, microRNAs are known to be involved in pain processing based on several recent findings in animal models of inflammatory and neuropathic pain. | ||
| 700 | 1 | |a Duroux, Meg |4 oth | |
| 700 | 1 | |a Gazerani, Parisa |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Academic Press |a Zhu, Chunqi ELSEVIER |t Rational administration sequencing of immunochemotherapy elicits powerful anti-tumor effect |d 2021 |g Orlando, Fla |w (DE-627)ELV007282540 |
| 773 | 1 | 8 | |g volume:71 |g year:2014 |g pages:159-168 |g extent:10 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.nbd.2014.08.003 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OPC-PHA | ||
| 936 | b | k | |a 44.40 |j Pharmazie |j Pharmazeutika |q VZ |
| 936 | b | k | |a 58.28 |j Pharmazeutische Technologie |q VZ |
| 951 | |a AR | ||
| 952 | |d 71 |j 2014 |h 159-168 |g 10 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
h h a hh hha |
|---|---|
| matchkey_str |
andersenhjaltehdurouxmeggazeraniparisa:2014----:irraamdltradimresfnlmaoynnuo |
| hierarchy_sort_str |
2014transfer abstract |
| bklnumber |
44.40 58.28 |
| publishDate |
2014 |
| allfields |
10.1016/j.nbd.2014.08.003 doi GBVA2014016000006.pica (DE-627)ELV039427641 (ELSEVIER)S0969-9961(14)00232-0 DE-627 ger DE-627 rakwb eng 610 570 610 DE-600 570 DE-600 540 610 VZ 15,3 ssgn PHARM DE-84 fid 44.40 bkl 58.28 bkl Andersen, Hjalte H. verfasserin aut MicroRNAs as modulators and biomarkers of inflammatory and neuropathic pain conditions 2014transfer abstract 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The post-transcriptional regulator molecules, microRNAs, have emerged as important biomarkers and modulators of numerous pathophysiological processes including oncogenesis and cardiovascular diseases. Recently, a significant number of dysregulations in microRNAs have been reported in patients suffering from painful disorders such as complex regional pain syndrome, cystitis-induced chronic pain and irritable bowel disorder, in both affected tissues and the circulation. Moreover, microRNAs are known to be involved in pain processing based on several recent findings in animal models of inflammatory and neuropathic pain. The post-transcriptional regulator molecules, microRNAs, have emerged as important biomarkers and modulators of numerous pathophysiological processes including oncogenesis and cardiovascular diseases. Recently, a significant number of dysregulations in microRNAs have been reported in patients suffering from painful disorders such as complex regional pain syndrome, cystitis-induced chronic pain and irritable bowel disorder, in both affected tissues and the circulation. Moreover, microRNAs are known to be involved in pain processing based on several recent findings in animal models of inflammatory and neuropathic pain. Duroux, Meg oth Gazerani, Parisa oth Enthalten in Academic Press Zhu, Chunqi ELSEVIER Rational administration sequencing of immunochemotherapy elicits powerful anti-tumor effect 2021 Orlando, Fla (DE-627)ELV007282540 volume:71 year:2014 pages:159-168 extent:10 https://doi.org/10.1016/j.nbd.2014.08.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.40 Pharmazie Pharmazeutika VZ 58.28 Pharmazeutische Technologie VZ AR 71 2014 159-168 10 045F 610 |
| spelling |
10.1016/j.nbd.2014.08.003 doi GBVA2014016000006.pica (DE-627)ELV039427641 (ELSEVIER)S0969-9961(14)00232-0 DE-627 ger DE-627 rakwb eng 610 570 610 DE-600 570 DE-600 540 610 VZ 15,3 ssgn PHARM DE-84 fid 44.40 bkl 58.28 bkl Andersen, Hjalte H. verfasserin aut MicroRNAs as modulators and biomarkers of inflammatory and neuropathic pain conditions 2014transfer abstract 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The post-transcriptional regulator molecules, microRNAs, have emerged as important biomarkers and modulators of numerous pathophysiological processes including oncogenesis and cardiovascular diseases. Recently, a significant number of dysregulations in microRNAs have been reported in patients suffering from painful disorders such as complex regional pain syndrome, cystitis-induced chronic pain and irritable bowel disorder, in both affected tissues and the circulation. Moreover, microRNAs are known to be involved in pain processing based on several recent findings in animal models of inflammatory and neuropathic pain. The post-transcriptional regulator molecules, microRNAs, have emerged as important biomarkers and modulators of numerous pathophysiological processes including oncogenesis and cardiovascular diseases. Recently, a significant number of dysregulations in microRNAs have been reported in patients suffering from painful disorders such as complex regional pain syndrome, cystitis-induced chronic pain and irritable bowel disorder, in both affected tissues and the circulation. Moreover, microRNAs are known to be involved in pain processing based on several recent findings in animal models of inflammatory and neuropathic pain. Duroux, Meg oth Gazerani, Parisa oth Enthalten in Academic Press Zhu, Chunqi ELSEVIER Rational administration sequencing of immunochemotherapy elicits powerful anti-tumor effect 2021 Orlando, Fla (DE-627)ELV007282540 volume:71 year:2014 pages:159-168 extent:10 https://doi.org/10.1016/j.nbd.2014.08.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.40 Pharmazie Pharmazeutika VZ 58.28 Pharmazeutische Technologie VZ AR 71 2014 159-168 10 045F 610 |
| allfields_unstemmed |
10.1016/j.nbd.2014.08.003 doi GBVA2014016000006.pica (DE-627)ELV039427641 (ELSEVIER)S0969-9961(14)00232-0 DE-627 ger DE-627 rakwb eng 610 570 610 DE-600 570 DE-600 540 610 VZ 15,3 ssgn PHARM DE-84 fid 44.40 bkl 58.28 bkl Andersen, Hjalte H. verfasserin aut MicroRNAs as modulators and biomarkers of inflammatory and neuropathic pain conditions 2014transfer abstract 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The post-transcriptional regulator molecules, microRNAs, have emerged as important biomarkers and modulators of numerous pathophysiological processes including oncogenesis and cardiovascular diseases. Recently, a significant number of dysregulations in microRNAs have been reported in patients suffering from painful disorders such as complex regional pain syndrome, cystitis-induced chronic pain and irritable bowel disorder, in both affected tissues and the circulation. Moreover, microRNAs are known to be involved in pain processing based on several recent findings in animal models of inflammatory and neuropathic pain. The post-transcriptional regulator molecules, microRNAs, have emerged as important biomarkers and modulators of numerous pathophysiological processes including oncogenesis and cardiovascular diseases. Recently, a significant number of dysregulations in microRNAs have been reported in patients suffering from painful disorders such as complex regional pain syndrome, cystitis-induced chronic pain and irritable bowel disorder, in both affected tissues and the circulation. Moreover, microRNAs are known to be involved in pain processing based on several recent findings in animal models of inflammatory and neuropathic pain. Duroux, Meg oth Gazerani, Parisa oth Enthalten in Academic Press Zhu, Chunqi ELSEVIER Rational administration sequencing of immunochemotherapy elicits powerful anti-tumor effect 2021 Orlando, Fla (DE-627)ELV007282540 volume:71 year:2014 pages:159-168 extent:10 https://doi.org/10.1016/j.nbd.2014.08.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.40 Pharmazie Pharmazeutika VZ 58.28 Pharmazeutische Technologie VZ AR 71 2014 159-168 10 045F 610 |
| allfieldsGer |
10.1016/j.nbd.2014.08.003 doi GBVA2014016000006.pica (DE-627)ELV039427641 (ELSEVIER)S0969-9961(14)00232-0 DE-627 ger DE-627 rakwb eng 610 570 610 DE-600 570 DE-600 540 610 VZ 15,3 ssgn PHARM DE-84 fid 44.40 bkl 58.28 bkl Andersen, Hjalte H. verfasserin aut MicroRNAs as modulators and biomarkers of inflammatory and neuropathic pain conditions 2014transfer abstract 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The post-transcriptional regulator molecules, microRNAs, have emerged as important biomarkers and modulators of numerous pathophysiological processes including oncogenesis and cardiovascular diseases. Recently, a significant number of dysregulations in microRNAs have been reported in patients suffering from painful disorders such as complex regional pain syndrome, cystitis-induced chronic pain and irritable bowel disorder, in both affected tissues and the circulation. Moreover, microRNAs are known to be involved in pain processing based on several recent findings in animal models of inflammatory and neuropathic pain. The post-transcriptional regulator molecules, microRNAs, have emerged as important biomarkers and modulators of numerous pathophysiological processes including oncogenesis and cardiovascular diseases. Recently, a significant number of dysregulations in microRNAs have been reported in patients suffering from painful disorders such as complex regional pain syndrome, cystitis-induced chronic pain and irritable bowel disorder, in both affected tissues and the circulation. Moreover, microRNAs are known to be involved in pain processing based on several recent findings in animal models of inflammatory and neuropathic pain. Duroux, Meg oth Gazerani, Parisa oth Enthalten in Academic Press Zhu, Chunqi ELSEVIER Rational administration sequencing of immunochemotherapy elicits powerful anti-tumor effect 2021 Orlando, Fla (DE-627)ELV007282540 volume:71 year:2014 pages:159-168 extent:10 https://doi.org/10.1016/j.nbd.2014.08.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.40 Pharmazie Pharmazeutika VZ 58.28 Pharmazeutische Technologie VZ AR 71 2014 159-168 10 045F 610 |
| allfieldsSound |
10.1016/j.nbd.2014.08.003 doi GBVA2014016000006.pica (DE-627)ELV039427641 (ELSEVIER)S0969-9961(14)00232-0 DE-627 ger DE-627 rakwb eng 610 570 610 DE-600 570 DE-600 540 610 VZ 15,3 ssgn PHARM DE-84 fid 44.40 bkl 58.28 bkl Andersen, Hjalte H. verfasserin aut MicroRNAs as modulators and biomarkers of inflammatory and neuropathic pain conditions 2014transfer abstract 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The post-transcriptional regulator molecules, microRNAs, have emerged as important biomarkers and modulators of numerous pathophysiological processes including oncogenesis and cardiovascular diseases. Recently, a significant number of dysregulations in microRNAs have been reported in patients suffering from painful disorders such as complex regional pain syndrome, cystitis-induced chronic pain and irritable bowel disorder, in both affected tissues and the circulation. Moreover, microRNAs are known to be involved in pain processing based on several recent findings in animal models of inflammatory and neuropathic pain. The post-transcriptional regulator molecules, microRNAs, have emerged as important biomarkers and modulators of numerous pathophysiological processes including oncogenesis and cardiovascular diseases. Recently, a significant number of dysregulations in microRNAs have been reported in patients suffering from painful disorders such as complex regional pain syndrome, cystitis-induced chronic pain and irritable bowel disorder, in both affected tissues and the circulation. Moreover, microRNAs are known to be involved in pain processing based on several recent findings in animal models of inflammatory and neuropathic pain. Duroux, Meg oth Gazerani, Parisa oth Enthalten in Academic Press Zhu, Chunqi ELSEVIER Rational administration sequencing of immunochemotherapy elicits powerful anti-tumor effect 2021 Orlando, Fla (DE-627)ELV007282540 volume:71 year:2014 pages:159-168 extent:10 https://doi.org/10.1016/j.nbd.2014.08.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.40 Pharmazie Pharmazeutika VZ 58.28 Pharmazeutische Technologie VZ AR 71 2014 159-168 10 045F 610 |
| language |
English |
| source |
Enthalten in Rational administration sequencing of immunochemotherapy elicits powerful anti-tumor effect Orlando, Fla volume:71 year:2014 pages:159-168 extent:10 |
| sourceStr |
Enthalten in Rational administration sequencing of immunochemotherapy elicits powerful anti-tumor effect Orlando, Fla volume:71 year:2014 pages:159-168 extent:10 |
| format_phy_str_mv |
Article |
| bklname |
Pharmazie Pharmazeutika Pharmazeutische Technologie |
| institution |
findex.gbv.de |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Rational administration sequencing of immunochemotherapy elicits powerful anti-tumor effect |
| authorswithroles_txt_mv |
Andersen, Hjalte H. @@aut@@ Duroux, Meg @@oth@@ Gazerani, Parisa @@oth@@ |
| publishDateDaySort_date |
2014-01-01T00:00:00Z |
| hierarchy_top_id |
ELV007282540 |
| dewey-sort |
3610 |
| id |
ELV039427641 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV039427641</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625224900.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.nbd.2014.08.003</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014016000006.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV039427641</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0969-9961(14)00232-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield><subfield code="a">570</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">15,3</subfield><subfield code="2">ssgn</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">PHARM</subfield><subfield code="q">DE-84</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.40</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">58.28</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Andersen, Hjalte H.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">MicroRNAs as modulators and biomarkers of inflammatory and neuropathic pain conditions</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">10</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The post-transcriptional regulator molecules, microRNAs, have emerged as important biomarkers and modulators of numerous pathophysiological processes including oncogenesis and cardiovascular diseases. Recently, a significant number of dysregulations in microRNAs have been reported in patients suffering from painful disorders such as complex regional pain syndrome, cystitis-induced chronic pain and irritable bowel disorder, in both affected tissues and the circulation. Moreover, microRNAs are known to be involved in pain processing based on several recent findings in animal models of inflammatory and neuropathic pain.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The post-transcriptional regulator molecules, microRNAs, have emerged as important biomarkers and modulators of numerous pathophysiological processes including oncogenesis and cardiovascular diseases. Recently, a significant number of dysregulations in microRNAs have been reported in patients suffering from painful disorders such as complex regional pain syndrome, cystitis-induced chronic pain and irritable bowel disorder, in both affected tissues and the circulation. Moreover, microRNAs are known to be involved in pain processing based on several recent findings in animal models of inflammatory and neuropathic pain.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Duroux, Meg</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gazerani, Parisa</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Academic Press</subfield><subfield code="a">Zhu, Chunqi ELSEVIER</subfield><subfield code="t">Rational administration sequencing of immunochemotherapy elicits powerful anti-tumor effect</subfield><subfield code="d">2021</subfield><subfield code="g">Orlando, Fla</subfield><subfield code="w">(DE-627)ELV007282540</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:71</subfield><subfield code="g">year:2014</subfield><subfield code="g">pages:159-168</subfield><subfield code="g">extent:10</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.nbd.2014.08.003</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-PHARM</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.40</subfield><subfield code="j">Pharmazie</subfield><subfield code="j">Pharmazeutika</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">58.28</subfield><subfield code="j">Pharmazeutische Technologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">71</subfield><subfield code="j">2014</subfield><subfield code="h">159-168</subfield><subfield code="g">10</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Andersen, Hjalte H. |
| spellingShingle |
Andersen, Hjalte H. ddc 610 ddc 570 ddc 540 ssgn 15,3 fid PHARM bkl 44.40 bkl 58.28 MicroRNAs as modulators and biomarkers of inflammatory and neuropathic pain conditions |
| authorStr |
Andersen, Hjalte H. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV007282540 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 570 - Life sciences; biology 540 - Chemistry & allied sciences |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 570 610 DE-600 570 DE-600 540 610 VZ 15,3 ssgn PHARM DE-84 fid 44.40 bkl 58.28 bkl MicroRNAs as modulators and biomarkers of inflammatory and neuropathic pain conditions |
| topic |
ddc 610 ddc 570 ddc 540 ssgn 15,3 fid PHARM bkl 44.40 bkl 58.28 |
| topic_unstemmed |
ddc 610 ddc 570 ddc 540 ssgn 15,3 fid PHARM bkl 44.40 bkl 58.28 |
| topic_browse |
ddc 610 ddc 570 ddc 540 ssgn 15,3 fid PHARM bkl 44.40 bkl 58.28 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
m d md p g pg |
| hierarchy_parent_title |
Rational administration sequencing of immunochemotherapy elicits powerful anti-tumor effect |
| hierarchy_parent_id |
ELV007282540 |
| dewey-tens |
610 - Medicine & health 570 - Life sciences; biology 540 - Chemistry |
| hierarchy_top_title |
Rational administration sequencing of immunochemotherapy elicits powerful anti-tumor effect |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV007282540 |
| title |
MicroRNAs as modulators and biomarkers of inflammatory and neuropathic pain conditions |
| ctrlnum |
(DE-627)ELV039427641 (ELSEVIER)S0969-9961(14)00232-0 |
| title_full |
MicroRNAs as modulators and biomarkers of inflammatory and neuropathic pain conditions |
| author_sort |
Andersen, Hjalte H. |
| journal |
Rational administration sequencing of immunochemotherapy elicits powerful anti-tumor effect |
| journalStr |
Rational administration sequencing of immunochemotherapy elicits powerful anti-tumor effect |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology 500 - Science |
| recordtype |
marc |
| publishDateSort |
2014 |
| contenttype_str_mv |
zzz |
| container_start_page |
159 |
| author_browse |
Andersen, Hjalte H. |
| container_volume |
71 |
| physical |
10 |
| class |
610 570 610 DE-600 570 DE-600 540 610 VZ 15,3 ssgn PHARM DE-84 fid 44.40 bkl 58.28 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Andersen, Hjalte H. |
| doi_str_mv |
10.1016/j.nbd.2014.08.003 |
| dewey-full |
610 570 540 |
| title_sort |
micrornas as modulators and biomarkers of inflammatory and neuropathic pain conditions |
| title_auth |
MicroRNAs as modulators and biomarkers of inflammatory and neuropathic pain conditions |
| abstract |
The post-transcriptional regulator molecules, microRNAs, have emerged as important biomarkers and modulators of numerous pathophysiological processes including oncogenesis and cardiovascular diseases. Recently, a significant number of dysregulations in microRNAs have been reported in patients suffering from painful disorders such as complex regional pain syndrome, cystitis-induced chronic pain and irritable bowel disorder, in both affected tissues and the circulation. Moreover, microRNAs are known to be involved in pain processing based on several recent findings in animal models of inflammatory and neuropathic pain. |
| abstractGer |
The post-transcriptional regulator molecules, microRNAs, have emerged as important biomarkers and modulators of numerous pathophysiological processes including oncogenesis and cardiovascular diseases. Recently, a significant number of dysregulations in microRNAs have been reported in patients suffering from painful disorders such as complex regional pain syndrome, cystitis-induced chronic pain and irritable bowel disorder, in both affected tissues and the circulation. Moreover, microRNAs are known to be involved in pain processing based on several recent findings in animal models of inflammatory and neuropathic pain. |
| abstract_unstemmed |
The post-transcriptional regulator molecules, microRNAs, have emerged as important biomarkers and modulators of numerous pathophysiological processes including oncogenesis and cardiovascular diseases. Recently, a significant number of dysregulations in microRNAs have been reported in patients suffering from painful disorders such as complex regional pain syndrome, cystitis-induced chronic pain and irritable bowel disorder, in both affected tissues and the circulation. Moreover, microRNAs are known to be involved in pain processing based on several recent findings in animal models of inflammatory and neuropathic pain. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA |
| title_short |
MicroRNAs as modulators and biomarkers of inflammatory and neuropathic pain conditions |
| url |
https://doi.org/10.1016/j.nbd.2014.08.003 |
| remote_bool |
true |
| author2 |
Duroux, Meg Gazerani, Parisa |
| author2Str |
Duroux, Meg Gazerani, Parisa |
| ppnlink |
ELV007282540 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth |
| doi_str |
10.1016/j.nbd.2014.08.003 |
| up_date |
2024-07-06T20:35:35.773Z |
| _version_ |
1803863338019454976 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV039427641</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625224900.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.nbd.2014.08.003</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014016000006.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV039427641</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0969-9961(14)00232-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield><subfield code="a">570</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">15,3</subfield><subfield code="2">ssgn</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">PHARM</subfield><subfield code="q">DE-84</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.40</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">58.28</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Andersen, Hjalte H.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">MicroRNAs as modulators and biomarkers of inflammatory and neuropathic pain conditions</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">10</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The post-transcriptional regulator molecules, microRNAs, have emerged as important biomarkers and modulators of numerous pathophysiological processes including oncogenesis and cardiovascular diseases. Recently, a significant number of dysregulations in microRNAs have been reported in patients suffering from painful disorders such as complex regional pain syndrome, cystitis-induced chronic pain and irritable bowel disorder, in both affected tissues and the circulation. Moreover, microRNAs are known to be involved in pain processing based on several recent findings in animal models of inflammatory and neuropathic pain.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The post-transcriptional regulator molecules, microRNAs, have emerged as important biomarkers and modulators of numerous pathophysiological processes including oncogenesis and cardiovascular diseases. Recently, a significant number of dysregulations in microRNAs have been reported in patients suffering from painful disorders such as complex regional pain syndrome, cystitis-induced chronic pain and irritable bowel disorder, in both affected tissues and the circulation. Moreover, microRNAs are known to be involved in pain processing based on several recent findings in animal models of inflammatory and neuropathic pain.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Duroux, Meg</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gazerani, Parisa</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Academic Press</subfield><subfield code="a">Zhu, Chunqi ELSEVIER</subfield><subfield code="t">Rational administration sequencing of immunochemotherapy elicits powerful anti-tumor effect</subfield><subfield code="d">2021</subfield><subfield code="g">Orlando, Fla</subfield><subfield code="w">(DE-627)ELV007282540</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:71</subfield><subfield code="g">year:2014</subfield><subfield code="g">pages:159-168</subfield><subfield code="g">extent:10</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.nbd.2014.08.003</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-PHARM</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.40</subfield><subfield code="j">Pharmazie</subfield><subfield code="j">Pharmazeutika</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">58.28</subfield><subfield code="j">Pharmazeutische Technologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">71</subfield><subfield code="j">2014</subfield><subfield code="h">159-168</subfield><subfield code="g">10</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.401045 |